Health Condition 1: L50- Urticaria
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinical diagnosis of erythematous wheal formation urticaria with UAS Score patients willing and able to to provide informed consent and to comply with the study protocol patients willing to stop using any treatment other than the investigational product for urticaria
Exclusion criteria
Exclusion criteria: Pregnant or lactation women Evidence of any skin condition other than urticaria Narcotic addicts and Angioneurotic oedema Other medications or disease that might directly interfere in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of the Trail Drug is measured using Urticaria Activity Score UASTimepoint: Changes in the Urticaria Activity Score will be assessed before and after treatment along with blood parameters after 40 day of Trail Period | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
National Institute of Siddha